The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Stock Idea & Analysis Community
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

 Mike Havrilla     www.ProActiveNewsRoom.com     Graphic_subscribe   

    Start Tracking Mike Havrilla  -  Add to Friends  -  Send Message   
    Community Rank: Principal (7000 pts)  |  Member since 07/15/2008
Mikerun
Picks Performance:
Outperforms
73%
of community

What's this?
All-time Return
+1.04%
(in 1 year) 		Risk (SD)
Conservative
0.00% 		Sharpe Ratio
-2.09
Followers
66 		Winning Picks
786 of 1807 		Total Views
875683


 Last Activity: Added EXAS to bullish list on 11/07/09 

Current Stock List:
Symbol SP Sentiment Rating Return Since
EXAS Positive +0.00% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.18% 11/04/09
MYL Positive +3.62% 11/04/09
DNDN Positive +8.08% 11/04/09
IYT Positive +2.27% 11/03/09
BRKA Positive +2.30% 11/03/09
BNI Positive -0.36% 11/03/09




Opinion & Analysis
Graphic_rating_buy EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Lon..   about EXAS   11/07/09
EXACT Sciences (NASDAQ: EXAS) is a molecular diagnostics company that is developing a next-generation (V3), stool DNA (sDNA) based screening test for colorectal cancer (CRC) which has demonstrated the...

Graphic_rating_buy ProActive HavRx Stock Indexes: Highlights and Oppor..   about NFES   11/07/09
Below is a summary and some charts for popular and top performers among the 22 ProActive HavRx global stock indexes . Despite the FDA filing by Dendreon (NASDAQ: DNDN) during the past week, th...

Graphic_rating_buy ProActive HavRx Stock Indexes: Highlights and Oppor..   about IMUC   11/07/09
Below is a summary and some charts for popular and top performers among the 22 ProActive HavRx global stock indexes . Despite the FDA filing by Dendreon (NASDAQ: DNDN) during the past week, th...

Graphic_rating_sell A 130 / 30 Global Pharma ETF Strategy   about ESALY   11/04/09
Investors who are bullish on the generic drug industry may consider implementing a 130 / 30 global pharma investing strategy through equal-weight (5% each) short positions for the six brand drug compa...

Graphic_rating_sell A 130 / 30 Global Pharma ETF Strategy   about PFE   11/04/09
Investors who are bullish on the generic drug industry may consider implementing a 130 / 30 global pharma investing strategy through equal-weight (5% each) short positions for the six brand drug compa...



Blog Posts

MM   ONTY   Oncothyreon (ONTY) Research Note 03/18/09   —  Visit the BioMedReports.com research section to view or download the PDF for Cougar Biotechnology (CGRB) along with other free PDF reports and corporate investor presentations:http://biomedreports.com/research.htmlOncothyreon (ONTY): Price: $1.21; Market Cap (MM): $23.6Market Outperform; Target Price...
+ Read 1 comment

MM   CGRB   Cougar Biotech Research Note 03/17/09   —  Visit the BioMedReports.com research section to view or download the PDF for Cougar Biotechnology (CGRB) along with other free PDF reports and corporate investor presentations:http://biomedreports.com/research.htmlCGRB: Price: $28.46; Market Cap (MM): $590.1Market Outperform; Target Price: $36.00Simo...
+ Read 0 comments

DRRX   UTHR   Updated Clinical Trial and FDA Calendars 03/17/09   —  Below is a summary of updates to the www.BioMedReports.com database of 243 entries included in the FDA and Clinical Trial Calendars.http://biomedreports.com/fda-calendar.html The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FD...
+ Read 0 comments

MM   SNTA   Synta Pharma Proceeds with Clinical Trial 03/17/09   —  Visit the BioMedReports.com research section to view or download the PDF for Synta Pharma (SNTA) along with other free PDF reports and presentations:http://biomedreports.com/research.htmlSynta Pharma: Price: $1.94; Market Cap (MM): $65.8Market Perform; Simos Simeonidis, Ph.D. - Senior Biotech Analyst...
+ Read 0 comments

MM   PARD   Poniard Pharma Awaits Key Cancer Drug Data 03/17/09   —  Visit the BioMedReports.com research section to view or download the six page PDF for Poniard Pharma (PARD) along with other free PDF reports and presentations:http://biomedreports.com/research.htmlPARD: Price: $1.87; Market Cap (MM): $64.9Market Outperform; Target Price: $10.00Simos Simeonidis, Ph.D...
+ Read 0 comments



Discussions

Mike Havrilla hasn't participated in any discussions yet.



People Following Mike Havrilla ...

My_pic_002
blackbirdk01
Analyst
N/A

Mgp
Mathieu Godbout Paquet
Principal
73%

Obi-wankenobi_main
mbmalone
Analyst
N/A

Mike Havrilla is Following ...

Redemption
Greg
Associate
73%

074
Jeremy McDonald
Associate
76%

Mgp
Mathieu Godbout Paquet
Principal
73%

Friends of Mike Havrilla ...

costas
Analyst
N/A

Mgp
Mathieu Godbout Paquet
Principal
73%

Redemption
Greg
Associate
73%





 
Similarity to Me   ?

Compare Your Portfolio With Mike Havrilla:
Enter stocks you like & get new ideas daily:

Symbols, separated by space (e.g. AAPL GOOG MSFT)



More about Mike Havrilla

Investment Style:
Moderate  [?]

Avg exp holding time:
81.99 days

Age:
30's

Occupation:
Online Media Entrepreneur

Location:
USA


Website:
www.ProActiveNewsRoom.com

About Me:
Mike Havrilla is an index developer, pharmacist, writer, and Co-Founder of BioMedReports.com with ex ... more


Similar Portfolios
Foto
Marian Filo (supratrade) 62% 55%
Art (unicomtrade.com) N/A 32%
Statistician (optimist) N/A 32%
Steven Halpern (trackstevenhalpern_bloggingstocks) 56% 21%
Zacks.com (zacks.com) 28% 21%



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch